Impact of inflammatory cytokine and adipokine gene variations in the development of HIV‐associated lipodystrophy

Cytokines affect lipid and glucose metabolism and also alter the body's habitus. They play a role in the development of lipodystrophy syndrome. Adipocytes secrete the pro-inflammatory cytokines IL-1, TNF-α and IL-6. The plasma cytokine concentration is associated with the percentage and distribution of fat tissue in the body. The metabolic disturbances are strongly associated with increased levels of pro-inflammatory cytokines (IL-1, IL-6 and TNF-α). Plasma levels of cytokines such as TNF-α, IL-6 and leptin were found to be increased while plasma resistin levels were found to be variable in patients suffering from obesity and type II diabetes mellitus. Until now, limited information has been available on the polymorphism of cytokine and adipokine genes in patients of HIV-associated lipodystrophy (HIVLD), which can contribute to individual variations in susceptibility to metabolic diseases, especially to HIVLD. Hence, we studied the association of cytokine and adipokine gene polymorphisms in various diseases and their impact on HIVLD. We carry out an extensive search using several databases, including PubMed, EMBASE and Google Scholar. The distribution of cytokine and adipokine gene polymorphisms and their expression levels varied among various populations. We examined the variants of cytokine and adipokine genes, which can contribute to individual variations in susceptibility to metabolic diseases, especially to HIVLD. In the current review, we present a brief account of the risk factors of HIVLD, the pathogenesis of HIVLD and the polymorphism of cytokine and adipokine genes in various diseases with special reference to their impact on HIVLD.

[1]  E. J. Belin de Chantemèle,et al.  HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women , 2022, JACC. Basic to translational science.

[2]  T. Swartz,et al.  NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease , 2020, Frontiers in Cardiovascular Medicine.

[3]  G. Soraya,et al.  Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia , 2020, Medicina Clínica.

[4]  Khalid Olajide Adekoya,et al.  Association of adiponectin gene (ADIPOQ) polymorphisms with measures of obesity in Nigerian young adults , 2018 .

[5]  N. Mesbah,et al.  Adiponectin (+276 G/T), Tumor Necrosis Factor-alpha (-308 G/A) and Interleukin-6 (-174 C/G) Genes Polymorphisms in Egyptian Type 2 Diabetic Patients , 2016 .

[6]  G. Dragović.  The role of adipokines in HIV lipodystrophy. , 2015, GERMS.

[7]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[8]  E. Blaak,et al.  Adipose Tissue Dysfunction and Impaired Metabolic Health in Human Obesity: A Matter of Oxygen? , 2015, Front. Endocrinol..

[9]  M. Fasshauer,et al.  Inflammatory Cytokines in General and Central Obesity and Modulating Effects of Physical Activity , 2015, PloS one.

[10]  R. Paranjape,et al.  Cardiac morbidity in an HIV-1 lipodystrophy patient cohort expressing the TNF-α-238 G/A single nucleotide gene polymorphism. , 2015, Current HIV research.

[11]  Kassem M. Makki,et al.  Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines , 2013, ISRN inflammation.

[12]  C. Mantzoros,et al.  Adipokines in the HIV/HAART-associated lipodystrophy syndrome. , 2013, Metabolism: clinical and experimental.

[13]  G. Vilahur,et al.  Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome , 2013, Mediators of inflammation.

[14]  D. D. de Luis,et al.  Relationship of Fat Distribution With Adipokines in Patients With Acquired Immunodeficiency Virus Infection , 2012, Journal of clinical laboratory analysis.

[15]  C. Richart,et al.  Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy. , 2012, Cytokine.

[16]  M. Colafigli,et al.  The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy. , 2011, AIDS research and human retroviruses.

[17]  F. Nociti,et al.  Interleukin-8 gene promoter polymorphism (rs4073) may contribute to chronic periodontitis. , 2011, Journal of periodontology.

[18]  F. Gong,et al.  -308 G > A of TNF-α gene promoter decreases the risk of multiple sclerosis: a meta-analysis , 2011, Multiple sclerosis.

[19]  J. Stewart,et al.  The IL1RN Promoter rs4251961 Correlates with IL-1 Receptor Antagonist Concentrations in Human Infection and Is Differentially Regulated by GATA-1 , 2011, The Journal of Immunology.

[20]  T. Lehtimäki,et al.  IL‐18 gene polymorphism, cardiovascular mortality and coronary artery disease , 2010, European journal of clinical investigation.

[21]  K. Tennekoon,et al.  Association of –2548 G/A Polymorphism in the Leptin Gene with Preeclampsia/Pregnancy-Induced Hypertension , 2010, Hypertension in pregnancy.

[22]  C. Mantzoros,et al.  The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications. , 2010, The Journal of infection.

[23]  Javier Martín,et al.  Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. , 2009, Human molecular genetics.

[24]  M. Feki,et al.  Association of G-2548A LEP polymorphism with plasma leptin levels in Tunisian obese patients. , 2009, Clinical biochemistry.

[25]  M. Balbi,et al.  Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[26]  C. Mantzoros.  Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome? , 2009, The Journal of clinical endocrinology and metabolism.

[27]  M. Schambelan,et al.  The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  K. Cianflone,et al.  Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents , 2009, International Journal of Obesity.

[29]  M. Pirmohamed,et al.  HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options. , 2008, The Journal of antimicrobial chemotherapy.

[30]  A. Hamsten,et al.  Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. , 2008, American journal of physiology. Endocrinology and metabolism.

[31]  P. Bhatnagar,et al.  From a glucocentric to a lipocentric approach towards metabolic syndrome. , 2008, Drug discovery today.

[32]  G. Bray,et al.  Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity , 2008, Expert review of cardiovascular therapy.

[33]  V. Appay,et al.  Immune activation and inflammation in HIV‐1 infection: causes and consequences , 2008, The Journal of pathology.

[34]  F. Villarroya,et al.  Lipodystrophy in HIV 1-infected patients: lessons for obesity research , 2007, International Journal of Obesity.

[35]  B. Mittal,et al.  Genetic association of interleukin-1β (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians , 2007 .

[36]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[37]  C. Mantzoros,et al.  Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications. , 2006, American journal of infectious diseases.

[38]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[39]  Y. Ko,et al.  G‐2548A Polymorphism of the Leptin Gene Is Correlated with Extreme Obesity in Taiwanese Aborigines , 2006, Obesity.

[40]  R. Ceddia,et al.  Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis , 2005, International Journal of Obesity.

[41]  P. Whincup,et al.  The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. , 2005, Atherosclerosis.

[42]  D. Spiegelman,et al.  Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  J. Capeau,et al.  Antiretroviral Drugs with Adverse Effects on Adipocyte Lipid Metabolism and Survival Alter the Expression and Secretion of Proinflammatory Cytokines and Adiponectin In Vitro , 2004, Antiviral therapy.

[44]  D. Kwiatkowski,et al.  Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility , 2004, Genes and Immunity.

[45]  N. Socci,et al.  Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. , 2004, The Journal of clinical investigation.

[46]  J. Albu,et al.  Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. , 2004, American journal of physiology. Endocrinology and metabolism.

[47]  P. Sucharda,et al.  Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. , 2003, European journal of endocrinology.

[48]  C. Mantzoros,et al.  Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus-positive subjects: a cross-sectional study. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  S. Maruoka,et al.  Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. , 2002, European journal of endocrinology.

[50]  Y. Matsuzawa,et al.  Serum adiponectin and leptin levels in patients with lipodystrophies , 2002 .

[51]  C. Dina,et al.  Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. , 2002, Diabetes.

[52]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[53]  J. Petit,et al.  Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV‐Hepatitis C Virus‐Coinfected Patients Undergoing Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.

[54]  C. Vigouroux,et al.  The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. , 2001, Diabetes.

[55]  I. Harman-boehm,et al.  The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes. , 2001, Diabetes.

[56]  D. Pessayre,et al.  Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice. , 2001, The Journal of pharmacology and experimental therapeutics.

[57]  Y. Minokoshi,et al.  Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. , 2001, Biochemical Society transactions.

[58]  V. Sasseville,et al.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.

[59]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[60]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Sergeant,et al.  Plasma Interferon α and the Wasting Syndrome in Patients Infected with the Human Immunodeficiency Virus , 1995 .

[62]  C. Fox,et al.  Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. , 1991, Journal of immunology.

[63]  S. Iyer,et al.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. , 2012, Critical reviews in immunology.

[64]  Jinquan Cheng,et al.  The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. , 2010, Biochemical and biophysical research communications.

[65]  K. Clément,et al.  Relationship between Single Nucleotide Polymorphisms in Leptin, IL6 and Adiponectin Genes and their Circulating Product in Morbidly Obese Subjects before and after Gastric Banding Surgery , 2005, Obesity surgery.

[66]  K. Park,et al.  Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. , 2004, The Journal of clinical endocrinology and metabolism.